Daily HIV Treatment Breakthrough Shows Promise

Daily HIV Treatment Breakthrough Shows Promise

0
Researchers at Queen Mary University of London have led the clinical development of the...
Sanofi’s rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the treatment of warm autoimmune hemolytic anemia

Sanofi’s rilzabrutinib designated breakthrough therapy in the US and orphan drug...

0
Sanofi’s rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the...
PRAME-Directed TCR Therapy Shows Unprecedented Responses in Metastatic Uveal Melanoma

PRAME-Directed TCR Therapy Shows Unprecedented Responses in Metastatic Uveal Melanoma

0
Dr Teresa Amaral reviews ESMO 2025 data showing unprecedented response rates with PRAME-directed TCR therapy in metastatic uveal melanoma. Source link
Global Breakthroughs: Cancer Reversed, Paralysis Cured, HPV Erased

Global Breakthroughs: Cancer Reversed, Paralysis Cured, HPV Erased

0
Breakthroughs in cancer treatment include a Spanish triple-drug combination that eliminated pancreatic tumors in mice for over 200 days and a Korean molecular switch...
Akeso Receives Fifth Breakthrough Therapy Designation from NMPA for Ivonescimab in First-Line Treatment of Advanced Biliary Tract Cancer

Akeso Receives Fifth Breakthrough Therapy Designation from NMPA for Ivonescimab in...

0
HONG KONG, Feb. 5, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) is pleased to announce that ivonescimab, its global first-in-class bispecific antibody...
Tampa General's Innovation Week Returns with New Programming to Showcase Breakthroughs in Patient Care and Technology

Tampa General’s Innovation Week Returns with New Programming to Showcase Breakthroughs...

0
Global leaders, entrepreneurs and innovators will converge across the Tampa Medical & Research District and TGH locations region-wide to showcase breakthrough technologies, bold ideas...
FDA Breakthrough Therapy Designation Granted for Litifilimab for Cutaneous Lupus

FDA Breakthrough Therapy Designation Granted for Litifilimab for Cutaneous Lupus

0
Results from the phase 2 LILAC study are key in gaining this FDA designation. Source link

Recent Posts